A combination of inhibitors may suppress tumor growth and prevent cancer relapse

An international team of researchers has demonstrated that a combination of inhibitors may suppress tumor growth and prevent relapse in patients with certain cancers, including head and neck squamous cell carcinoma and lung adenocarcinoma.

Resilience cuts 120 employees at a former bluebird gene therapy site

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 9, 2025

TyG index linked to obesity measures can predict hypertension risk in US adults

A study found that the triglyceride-glucose (TyG) index, combined with obesity measures, significantly correlates with hypertension risk in American adults, offering potential for improved cardiovascular

January 20, 2025

PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 – Biotech Investments

PharmaSGP Holding SE / Key word(s): Dividend PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 18-Apr-2024 / 20:31 CET/CEST

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.